
May 5 (Reuters) - UNITY Biotechnology Inc UBX.O:
UNITY BIOTECHNOLOGY INC - COMPANY ESTIMATES $3.7 MILLION CASH EXPENSES FOR REDUCTION IN FORCE - SEC FILING
UNITY BIOTECHNOLOGY INC - REDUCTION IN FORCE EXPECTED TO BE COMPLETED BY MAY 15, 2025 - SEC FILING
UNITY BIOTECHNOLOGY INC - CEO ANIRVAN GHOSH, CFO LYNNE SULLIVAN, AND ALEXANDER NGUYEN TO TERMINATE EMPLOYMENT - SEC FILING
Source text: [ID:n0000950170-25-063167]